GANX - Gain Therapeutics names Gene Mack as Interim CEO
2024-06-27 16:37:22 ET
More on Gain Therapeutics
- Gain Therapeutics: Phase 1 Readout Awaits For Parkinson's Drug With Great Potential
- Gain Therapeutics shares slide on pricing public offering of units to raise $11M
- Gain Therapeutics shares fall on proposed public offering
- Seeking Alpha’s Quant Rating on Gain Therapeutics
- Historical earnings data for Gain Therapeutics